I heard PAC partners have placed a 59 mill valuation from their Dcf model Can easily up the price for higher revenues and this is without looking at expansion into other markets/countries My only concern is the register
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025